menu
    • menu

    Company profile for iNtRON Biotechnology

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    iNtRON Bio has been focusing on the R&D investment since its foundation and accelerates development speed after the IPO in KOSDAQ. We are aiming for the ‘global R&D company’ ; and promoting the value of the company focused on the BIO New Drug by developing various ‘First-in-Class’ bio-drugs and conducting clinical studies in phases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    iNtRON Biotechnologykorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    137 Sagimakgol-ro, Jungwon-gu, Seongnam-si, Gyeonggi-do (Sangdaewon-dong, Jung...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    http://www.intron.co.kr/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    iNtRON Bio Shows IMPA Phage Tech Neutralizes Toxin in CRC Model
    iNtRON Bio Shows IMPA Phage Tech Neutralizes Toxin in CRC Model

    06 Aug 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-bio-demonstrated-toxin-neutralizing-effect-of-impa-phage-engineering-technology-in-colorectal-cancer-model-and-completed-the-us-patent-application-302521505.html

    PR NEWSWIRE
    06 Aug 2025
    Share Share
    iNtRON Seeks Strategic Partner for MRSA Decolonization Market
    iNtRON Seeks Strategic Partner for MRSA Decolonization Market

    13 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-seeks-a-strategic-partner-to-explore-the-promising-market-for-mrsa-decolonization-302453247.html

    PR NEWSWIRE
    13 May 2025
    Share Share
    iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology
    iNtRON, Development of PHAGERIA® Anti-Cancer Candidate with Enhanced Antimicrobial Activity by Robot Bacteriophage platform technology

    14 Feb 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-development-of-phageria-anti-cancer-candidate-with-enhanced-antimicrobial-activity-by-robot-bacteriophage-platform-technology-302062490.html

    PR NEWSWIRE
    14 Feb 2024
    Share Share
    iNtRON, Executes Evaluation License and Option Agreement for SAL200
    iNtRON, Executes Evaluation License and Option Agreement for SAL200

    30 Oct 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-executes-evaluation-license-and-option-agreement-for-sal200-301972235.html

    PR NEWSWIRE
    30 Oct 2023
    Share Share
    iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM
    iNtRON Signs Bacteriophage Development Project with U.S. Army DEVCOM

    03 Sep 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-signs-bacteriophage-development-project-with-us-army-devcom-301916586.html

    PR NEWSWIRE
    03 Sep 2023
    Share Share
    iNtRON identifies Prophage &Jamphage in the Pancreatic cancer related Microbiome
    iNtRON identifies Prophage &Jamphage in the Pancreatic cancer related Microbiome

    29 May 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/intron-identifies-prophage-and-jamphage-in-the-pancreatic-cancer-related-microbiome-301836795.html

    PR NEWSWIRE
    29 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search